Xilio Therapeutics, Inc.

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

Xilio Therapeutics, Inc. filed this to disclose a change in directors or executive officers appointments, departures, or role changes that can signal a strategic shift.